Literature DB >> 1416901

Effect of biliary obstruction on the hepatic excretion of imipenem-cilastatin.

J W Leung1, C Y Chan, C W Lai, T C Ko, A F Cheng, G L French.   

Abstract

The biliary excretion of imipenem-cilastatin studied by endoscopic cannulation of the common bile duct in patients with complete obstruction and in a group without obstruction showed that despite a 24-h prophylaxis, the bile obtained from patients with obstruction immediately after cannulation contained neither imipenem nor cilastatin, while there were 2 and 5% of peak concentrations in serum for imipenem and cilastatin, respectively, in the bile from patients without obstruction. Biliary excretion of both compounds increased rapidly after decompression, reaching a maximum of 15% of peak levels in serum within 2 h. Twenty-four hours after drainage, the biliary excretion of the drugs further improved. We conclude that since biliary obstruction impairs excretion of antibiotics, drainage is necessary for the control of sepsis in obstructed cholangitis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1416901      PMCID: PMC192439          DOI: 10.1128/AAC.36.9.2057

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Acute obstructive cholangitis; a distinct clinical syndrome.

Authors:  B M REYNOLDS; E L DARGAN
Journal:  Ann Surg       Date:  1959-08       Impact factor: 12.969

2.  Bacteriological and electron microscopy examination of brown pigment stones.

Authors:  J W Leung; J Y Sung; J W Costerton
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

3.  Estimation of the biliary excretion of different cephalosporins utilizing retrograde cholangio-pancreatography (ERCP).

Authors:  E E Ohnhaus; F Halter; G Lebek
Journal:  Endoscopy       Date:  1981-01       Impact factor: 10.093

4.  Antibiotics in bile.

Authors:  M Thomas
Journal:  J Antimicrob Chemother       Date:  1983-11       Impact factor: 5.790

5.  Pharmacokinetics of imipenem in healthy volunteers.

Authors:  S R Norrby; B Björnegård; F Ferber; K H Jones
Journal:  J Antimicrob Chemother       Date:  1983-12       Impact factor: 5.790

6.  The effect of obstruction on the biliary excretion of cefoperazone and ceftazidime.

Authors:  J W Leung; R C Chan; S W Cheung; J Y Sung; S C Chung; G L French
Journal:  J Antimicrob Chemother       Date:  1990-03       Impact factor: 5.790

7.  Urgent endoscopic drainage for acute suppurative cholangitis.

Authors:  J W Leung; S C Chung; J J Sung; V P Banez; A K Li
Journal:  Lancet       Date:  1989-06-10       Impact factor: 79.321

Review 8.  Review of the in vitro spectrum of activity of imipenem.

Authors:  R N Jones
Journal:  Am J Med       Date:  1985-06-07       Impact factor: 4.965

9.  Management of malignant obstructive jaundice at The Middlesex Hospital.

Authors:  J W Leung; R Emery; P B Cotton; R C Russell; A G Vallon; R R Mason
Journal:  Br J Surg       Date:  1983-10       Impact factor: 6.939

Review 10.  Antibacterial activity of imipenem: the first thienamycin antibiotic.

Authors:  H Kropp; L Gerckens; J G Sundelof; F M Kahan
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug
View more
  2 in total

1.  Pharmacokinetics and clinical study of cefotetan in bile: prophylactic use in biliary tract surgery.

Authors:  P Cherrier; P Perrin; S Gueye; A M Bosio; P Tinel; P Blot; R Richer; F Fauvelle
Journal:  Pharm World Sci       Date:  1993-04-23

2.  Antimicrobial therapy for acute cholangitis: Tokyo Guidelines.

Authors:  Atsushi Tanaka; Tadahiro Takada; Yoshifumi Kawarada; Yuji Nimura; Masahiro Yoshida; Fumihiko Miura; Masahiko Hirota; Keita Wada; Toshihiko Mayumi; Harumi Gomi; Joseph S Solomkin; Steven M Strasberg; Henry A Pitt; Jacques Belghiti; Eduardo de Santibanes; Robert Padbury; Miin-Fu Chen; Giulio Belli; Chen-Guo Ker; Serafin C Hilvano; Sheung-Tat Fan; Kui-Hin Liau
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-01-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.